WX [WuXi PharmaTech (Cayman)] UPLOAD: (Original Filing)
[]
CPHI [CHINA PHARMAS,] PRE 14C: SCHEDULE 14C INFORMATION Amendment No. 1 X] [
[SCHEDULE 14C INFORMATION Amendment No. 1 X] [ Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13D/A: (Original Filing)
[1 Name of Reporting Person Barron Partners LP I.R.S. Identification No. of Above Person 43-1981699 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds WC Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware Number of 7 Sole Voting Power]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13D/A: 1 Name of Reporting Person Barron Partners LP
[1 Name of Reporting Person Barron Partners LP I.R.S. Identification No. of Above Person 43-1981699 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds WC Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware Number of 7 Sole Voting Power]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13D/A: (Original Filing)
[SCHEDULE 13D/A (Amendment 2)ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock (Title of Class of Securities) 830884201 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) September 8, 2009 (Date of Event which Requires Filing of this Statement) If the filing]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13D/A: SCHEDULE 13D/A (Amendment 2)ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon
[SCHEDULE 13D/A (Amendment 2)ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock (Title of Class of Securities) 830884201 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) September 8, 2009 (Date of Event which Requires Filing of this Statement) If the filing]
SVA [SINOVAC BIOTECH] SC 13G/A: (Original Filing)
[CUSIP No. P8696W104 13G Page 2 of 9 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Sanjay Motwani 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*]
SVA [SINOVAC BIOTECH] SC 13G/A: CUSIP No. P8696W104 13G Page 2 of 9
[CUSIP No. P8696W104 13G Page 2 of 9 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Sanjay Motwani 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*]
SVA [SINOVAC BIOTECH] S-8:
[] [[Letterhead of Rhudd & Associates] September 10, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) As Antigua and Barbuda legal counsel to the Company, we have examined (i) the Registration Statement, (ii) the Plan, (iii) the articles of incorporation and by-laws of the Company, and] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, September 10, 2009 Chartered Accountants EX-23.1 3 dex231.htm CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM]
